NCT04020822View on ClinicalTrials.gov

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 29, 2019

Primary Completion Date

August 27, 2019

Study Completion Date

August 27, 2019

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
DEVICE

Guardian Sensor (3)

Guardian Sensor (3) connected to Guardian Link (3) Transmitter and/or Guardian Connect Transmitter.

Trial Locations (2)

30318

Atlanta Diabetes Associates, Atlanta

80045

Barbara Davis Center for Diabetes, Aurora

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT04020822 - Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices | Biotech Hunter | Biotech Hunter